Get Ready to Geek Out: Actuate Takes the Stage at H.C. Wainwright’s 26th Annual Global Investment Conference!

marketnews04 mins

Welcome to the Actuate Therapeutics Blog! Actuate Therapeutics Set to Present at H.C. Wainwright Annual Global Investment Conference Exciting news alert! Actuate Therapeutics, a leading biopharmaceutical company focusing on innovative cancer treatments, will be showcasing their latest developments at the prestigious H.C. Wainwright Annual Global Investment Conference in New York City. What does this mean…

Read More

“PA American Water Secures $19.3 Million in PENNVEST Funding for Water and Wastewater Infrastructure Upgrades”

newscaster03 mins

The Shapiro administration recently announced that Pennsylvania American Water was awarded two low-interest loans and a grant from the Pennsylvania Infrastructure Investment Authority (PENNVEST) totaling $19.3 million. Infrastructure Improvement Projects The funding will support two of the company’s infrastructure improvement projects, including wastewater treatment plant upgrades and the replacement of lead water services lines in…

Read More

“Calling All Investors: Join the Investigation with Bronstein, Gewirtz, and Grossman LLC!”

newsmaker04 mins

Oh, Mergers and Acquisitions: A Rollercoaster Ride for Investors Are you one of the brave souls daring to hold on? January 26, 2025 So, you’ve invested in Liberty TripAdvisor Holdings, Inc. (“Liberty TripAdvisor”) (OTCMKTS:LTRPA) and stuck around for the merger with TripAdvisor. How’s that going for you? Bronstein, Gewirtz & Grossman, LLC are looking into…

Read More

Roche Receives FDA Approval for First Companion Diagnostic to Identify Patients with HER2 Ultralow Metastatic Breast Cancer Eligible for ENHERTU

financenews05 mins

Roche Receives FDA Approval for Expanded Label of PATHWAY® Antibody Basel, 31 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) Roche, a leading healthcare company, made a significant announcement today regarding the approval from the U.S. Food and Drug Administration (FDA) for an expanded label of the PATHWAY® anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody*….

Read More

“Attention all Block Inc. investors! Don’t miss out on this important deadline for your securities class action case. Get the scoop from ROSEN GLOBAL INVESTOR COUNSEL before it’s too late!”

marketsgonewild04 mins

Welcome to the Wild World of Class Action Lawsuits Oh, the Drama! It’s not every day that you hear about a class-action lawsuit being filed, especially when it involves a big company like Block, Inc. But that’s exactly what happened in the bustling city of New York on January 24, 2025. The Rosen Law Firm,…

Read More